Cite
HARVARD Citation
Colombel, J. et al. (2017). The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut. 66 (5), pp. 839-851. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Colombel, J. et al. (2017). The safety of vedolizumab for ulcerative colitis and Crohn's disease. Gut. 66 (5), pp. 839-851. [Online].